Navigation Links
Blue Cross and Blue Shield of Illinois Announces One Millionth E- Prescription in Illinois
Date:8/10/2009

Over 143,000 drug/allergy errors flagged; 27% of scripts changed, cancelled

CHICAGO, Aug. 10 /PRNewswire-USNewswire/ -- Blue Cross and Blue Shield of Illinois (BCBSIL) announced today that physicians and health care providers in the Illinois E-Prescribing Collaborative reached a major milestone in their e-prescribing efforts - the one millionth "e-prescription" was transmitted electronically last month.

"E-prescribing enhances patient care and prevents errors," says Scott Sarran, M.D., BCBSIL's chief medical officer. "E-prescribing reduces the potential for drug interactions, which can be extremely harmful, and even fatal in some cases, and it can eliminate the potential for errors that can occur if pharmacists can't read hand-written prescriptions."

E-prescribing's benefits

Once they determine which medication is most appropriate for the patients, physicians use automated data entry systems, such as desktop computers, handheld devices or personal computer tablets, to submit prescriptions electronically to patients' pharmacies of choice. E-prescribing gives physicians real-time access to important safety and prescription coverage information, which can inform their prescribing decisions. The technology has been widely recognized for its ability to improve patient safety, increase practice efficiency and reduce costs.

Sarran says that since BCBSIL launched the e-prescribing program in April 2007, more than 119,000 possible drug interactions have been flagged. As a result, nearly 20 percent of prescriptions were changed or cancelled.

Based on national trends, more than 670,000 prescriptions will be changed and cancelled in 2009, due to drug interaction warnings, and more than 53,600 prescriptions will be changed or cancelled due to drug allergy warnings.

The Ins
'/>"/>

SOURCE Blue Cross and Blue Shield of Illinois
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Red Cross Poll Shows Parents Still Lack H1N1 Information From Schools
2. Blue Cross Blue Shield of Michigan, Michigan Attorney General and Michigan Office of Financial and Insurance Regulation Near Agreement on Rate Increases on Under Age 65 Individual Products
3. Efforts by Blue Cross Blue Shield of Michigan, Physician Practices Help Michigan Become a Leading Adopter of E-prescribing
4. Blue Cross and Blue Shield Association Introduces Interactive Navigation Solution That Helps Individuals and Families Find Healthcare Coverage Options
5. Larry Schreiber Named President of Anthem Blue Cross and Blue Shield in Wisconsin
6. Anthem Blue Cross and Blue Shield in Missouri Harnesses Social Media to Interact with Members
7. Judge Sues Blue Cross for Autism Treatment
8. Blue Cross and Blue Shield of Texas Collaborates With Five Blue Plans to Increase Transparency, Expand Access to Health Care Cost Information
9. WellPoint, BCBSA, Blue Cross Blue Shield of Florida and HCSC Collaborate to Expand Access to Health Care Cost Information
10. Eagles to Host 2nd Annual American Red Cross Training Camp Blood Drive
11. People Across the Country are Making The Switch!
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... (PRWEB) August 28, 2014 Save ... Healthbox tech accelerator program in Tampa. Healthbox Florida ... innovative healthcare companies grow and achieve their goals. ... August 16th, at their launch event at the Mahaffey ... professionals. , Co-founder Matt Schneider commented on the Save ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 As September ... the more than 100 million people who suffer from ... from the Committee on Advancing Pain Research, Care, and ... of Health, is defined as any pain lasting more ... longer. And while chronic pain causes range from injury ...
(Date:8/28/2014)... 2014 ISI Telemanagement Solutions, Inc., ... be sponsoring the 2014 Presidio Exchange this September ... Presidio leadership to engage with the community with ... will be rolling out objectives for representatives to ... the event, ISI will be discussing their growing ...
(Date:8/28/2014)... CA (PRWEB) August 28, 2014 Commercial growers ... changing, new Kind K5 series LED grow lights, which perform ... Besides the wattage savings, Kind LED lighting needs no cooling ... room requires less cooling as well. Factoring in that they ... LED lighting is less than a year. , For many ...
(Date:8/28/2014)... 2014 Following the death of an 18-year-old ... FDA issued a warning on powdered caffeine products. ... substance that is readily available to consumers, despite the fact ... senior Logan Stiner died from an overdose of caffeine powder. ... the FDA to issue a safety advisory for caffeine powders. ...
Breaking Medicine News(10 mins):Health News:Save On Medical Accepted Into Healthbox Accelerator Program 2Health News:Interventional Pain Management Expert Glenn M. Lipton, M.D. Shares Common-Sense Tips for Preventing Chronic Pain 2Health News:Interventional Pain Management Expert Glenn M. Lipton, M.D. Shares Common-Sense Tips for Preventing Chronic Pain 3Health News:ISI Telemanagement Solutions, Inc. to Sponsor 2014 Presidio Exchange 2Health News:New Kind K5 Series LED Grow Lights Pave Way for Future of Indoor Gardening 2Health News:FDA Issues Safety Advisory for Caffeine Powders 2
... ... Legal Hold Pro™ service into doeDiscovery™. Further expanding doeLegal,s capabilities across the entire spectrum ... to offer increased value to all eDiscovery clients. , ... (PRWEB) May 14, 2010 -- doeLegal, ...
... at ethical issues arising from new neuroimaging research suggesting ... injury might be able to communicate. Title: Severe ... Andrew Billings, Larry R. Churchill, and Richard Payne, Summary: ... meaningful existence? The authors contend that "modern neuroscience ...
... ... in science , ... New York, NY (Vocus) May 13, 2010 -- Mount Sinai School of Medicine at ... of genetics and human genome research, and renowned humanists whose work has advanced biomedical ...
... ... for its many customers who have been touched by cancer, CIGNA expands access to all ... ... of access, quality and choice for its many customers who have been touched by cancer, ...
... 20 people over age 65, experts note, , THURSDAY, ... common irregular heartbeat known as atrial fibrillation in a ... and other forms of dementia, new research finds. , ... beat chaotically, causing blood to pool and increasing the ...
... blood test could spot those who need more supplementation, ... Seventy percent of pregnant women in the United States ... What,s more, the regimen of prenatal vitamins that many ... to boost levels when needed, researchers from the University ...
Cached Medicine News:Health News:doeLegal and Zapproved Sign Alliance to Add Legal Hold Pro to Suite of Powerful Online Legal Solutions 2Health News:doeLegal and Zapproved Sign Alliance to Add Legal Hold Pro to Suite of Powerful Online Legal Solutions 3Health News:The Hastings Center Report table of contents for May/June 2010 2Health News:The Hastings Center Report table of contents for May/June 2010 3Health News:Mount Sinai School of Medicine Commencement Honors Leaders in Genetics and Global Health 2Health News:Mount Sinai School of Medicine Commencement Honors Leaders in Genetics and Global Health 3Health News:Mount Sinai School of Medicine Commencement Honors Leaders in Genetics and Global Health 4Health News:Mount Sinai School of Medicine Commencement Honors Leaders in Genetics and Global Health 5Health News:Mount Sinai School of Medicine Commencement Honors Leaders in Genetics and Global Health 6Health News:CIGNA and Cancer Treatment Centers of America Reach New Agreement 2Health News:Treating Common Irregular Heartbeat Might Also Ward Off Alzheimer's 2Health News:Treating Common Irregular Heartbeat Might Also Ward Off Alzheimer's 3Health News:Many Pregnant Woman Not Getting Enough Vitamin D 2
(Date:8/28/2014)... 2014 Levi & Korsinsky announces that a ... States District Court for the District of ... Galectin Therapeutics Inc. ("Galectin" or the "Company") (NasdaqCM: GALT) ... For more information, click here: http://zlk.9nl.com/galectin-therapeutics-galt ... Class Period the Company violated federal securities laws by ...
(Date:8/28/2014)... LONDON , Aug. 28, 2014  A candidate ... The Gambia and Mali ... safety trials of potential vaccines aimed at preventing the disease that ... West Africa . Human trials of ... Health (NIH) and GlaxoSmithKline, are to be accelerated with funding from ...
(Date:8/28/2014)... , Aug. 28, 2014 Nonin Medical, Inc., ... in noninvasive medical monitoring, today announced that the Food ... 3231 OEM/eHealth finger pulse oximeter for use in ... oximeter plugs into a telemedicine hub or kiosk through ... rate in pediatric to adult patients. The Model 3231 ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 29, 2014 -- GALT 2Ebola vaccine trials fast-tracked by international consortium 2Ebola vaccine trials fast-tracked by international consortium 3Ebola vaccine trials fast-tracked by international consortium 4Ebola vaccine trials fast-tracked by international consortium 5Ebola vaccine trials fast-tracked by international consortium 6Ebola vaccine trials fast-tracked by international consortium 7Nonin Medical Announces FDA Clearance of Nonin Model 3231 USB Pulse Oximeter 2
... New study finds patients who opt for surgery have decreased pain, ... with the spine disease called degenerative spondylolisthesis * ... pain over time compared to those who do not have surgery, ... The Journal of Bone and Joint Surgery ...
... GAITHERSBURG, Md., June 1 Overall survival data in ... GenVec,s ongoing Phase III Pancreatic Cancer Clinical Trial with ... Society of Clinical Oncology Annual Meeting in Orlando, FL. ... ) , , The poster ...
Cached Medicine Technology:Back to Normal: Surgery Improves Outcomes for Spine Patients 2Back to Normal: Surgery Improves Outcomes for Spine Patients 3Back to Normal: Surgery Improves Outcomes for Spine Patients 4TNFerade(TM) Phase III Data Presented at ASCO 2TNFerade(TM) Phase III Data Presented at ASCO 3